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The alcohol dehydrogenase from Lactobacillus brevis (LbADH) is a versatile cata-
lyst for enantioselective reduction of ketones. Its substrate scope is wide with high regio-
and enantioselectivity. In this critical review, we have gathered the information available
on the substrate scope as well as the applications reported. Quantitative information such
as productivity per catalyst, space-time yield (STY), cofactor utilisation, and stability are
derived to allow comparison and assessment of practical value.
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Introduction
The upcoming demand for enantiopure inter-
mediates in the fine chemicals- and pharma-indus-
try makes biocatalysis an increasingly profitable al-
ternative to conventional chemical catalysis/synthe-
sis.1,2 Also, as the environmental footprint of a pro-
cess is gaining increased attention, biocatalytic pro-
cesses come to the focus of the chemical industry.
The generally mild reaction conditions (moderate
pH, low T, aqueous solution, no heavy metals)
which characterise biocatalysis enhance this effect.
Over the years, hydrolases such as Lipase B
from Candida antarctica (CALB) have been domi-
nating industrial biocatalysis due to their stability
and robustness even in the presence of organic sol-
vents and reactants.
The application of alcohol dehydrogenase from
Lactobacillus brevis (LbADH) is rising as reflected
in the number of publications (Fig. 2), while the
number of patent applications for this enzyme is
also an indication of its potential3–19 LbADH is a ro-
bust and versatile enzyme which catalyses the
enantioselective reduction of ketones to the corre-
sponding alcohols and requires NADPH (+H+) as
reduction equivalent (Fig. 1). Even in the presence
of non-conventional reaction media, such as or-
ganic solvents, supercritical fluids (scF), or gaseous
reactants, LbADH remains active. The excellent
chemo- and enantioselectivity makes LbADH a
valuable tool for the synthesis of chiral building
blocks. In most cases exclusively (R)-alcohols are
formed (typical enantiomeric excess (ee)>0.99, see
below). The high activity of LbADH for a broad
range of substrates (from simple aromatic ketones
and keto-esters to branched acetophenone deriva-
tives, see Fig. 4), is one factor for the ongoing and
growing interest for this catalyst. Another factor for
the rising interest is that LbADH is among the few
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F i g . 1 – General reaction scheme for the LbADH-catalysed
reduction of a ketone to the corresponding R-alcohol and co-
factor-regeneration, with R2 >R1
F i g . 2 – Publications per year since discovery in 1996
(light grey: patents, dark grey: peer reviewed pub-
lications)
oxidoreductases with high solvent tolerance for
monophasic systems with solvent addition as well
as in biphasic media.
A number of reviews are available, such as
Hummel20 presenting different enzymes for the syn-
thesis of chiral compounds, Nakamura et al.21 and
Daußmann et al.22 for general aspects of producing
chiral alcohols, Eckstein et al., Hollmann et al.,
Wichmann and Vasic-Racki23–25 for cofactor regen-
eration and Müller et al.26 for a more detailed in-
sight into the asymmetric reduction of 3,5-dioxo-
carboxylates and propargylic ketones.
Here, we have gathered the information avail-
able on the LbADH in view of its promising activ-
ity and stability. To allow comparability, additional
values following the guidelines given in Gardossi et
al.27 were calculated from the information as de-
rived by the authors. To enable practical compari-
son not at least in view of optimisation potential,
we focused on space time yield (STY) as productiv-
ity per unit volume of the reactor, absolute produc-
tivity per catalyst amount used to derive the prod-
uct, and cofactor utilisation, thereby allowing a
shorthand assessment of practical applicability. Oc-
casionally, these rigid definitions led to values
given within this review that differ from the ones in
the original articles. Sometimes, the necessary data
for the calculations could not be derived from the
article alone; the corresponding authors were con-
tacted to gather further information. Where possi-
ble, PhD theses were consulted for additional infor-
mation. A table providing an additional overview
can be found as electronic supporting information
(ESI).
Enzyme technology
The LbADH was discovered by Hummel and
coworkers during a screening in the class of Lacto-
bacillus and has close homology to the alcohol de-
hydrogenase from Lactobacillus kefir (LkADH).28
Although, the enzymes are closely related in view
of amino acid sequence with only 18 residues dif-
ference LbADH is found to be exceptionally more
stable than LkADH, thus a 10-fold higher yield
could be achieved by the same purification proto-
col.20,28 Its recombinant expression in Escherichia
coli (E. coli) is also highly efficient and convenient
purification protocols are available which are possi-
ble because of the high robustness the enzyme
shows throughout.3,28 The metabolic role is un-
known28 which, with the increasing significance of
metagenomics and other screening strategies, will
be more and more common for industrially used en-
zymes.
The LbADH is classified as a short chain
dehydrogenase/reductase (enzyme class EC 1.1.1.2,
CAS 9031-72-5).29 It is denoted as R-selective. This
is applicable when the formal Cahn-Ingold-Prelog
priorities (CIP) match the steric demand which is
coincidentally often but not necessarily the case.30,31
For the application of LbADH the most prominent
exception are -halogen substituted ketones where
the (S)-product is formed but the intrinsic selectiv-
ity or side of hydride addition to the prochiral
ketone does not change as compared to the
non-substituted homologue (see below).32 The term
R-selective is most often used to set the enzymes
apart from the previously known ADH as with the
same substrate the opposite enantiomer is derived.
The LbADH was among the first commercially
available dehydrogenases opening up the venue for
these enantiomers. It is patented by a non-profit or-
ganisation and thus commonly available at reason-
able terms as the commercial availability by en-
zyme suppliers underlines.3,33 It is industrially ap-
plied for the production of ethyl-3R-hydroxy-bu-
tanoate on a scale of one ton per year (see be-
low).22,34,35
The enzyme is a homotetramer29,36 with molec-
ular mass between 104–107 kDa20,36 with mono-
mers of 26 kDa36,37 or 22.5 kDa28 depending on the
source.
The DNA and amino acid sequence was pub-
lished.3,20 The high resolution crystal structure for
both, the apoenzyme and holoenzyme are also
available (wild type: protein data bank code
1NXQ29 and 1ZK4, mutant G37D: 1ZK4 1ZJY,
1ZJZ, 1ZK0, 1ZK1, 1ZK2, 1ZK337). The high-res-
olution crystal structure 1ZJY was used as homology
model for the computational study of the ADH
from Lactobacillus kefir reduction of ethanal with
deuterated NADPH.38 An ample discussion of the
implications of the active site can be found in
Schlieben et al.37 The stereospecificity can be ex-
plained by inspection of the three-dimensional
model of the active site.29 Also, in a comparative
study the suitability for four diketones was investi-
gated.39
The NADP+-dependence of LbADH is viewed
as a drawback and reaction engineering challenge,
as compared to NAD+ the phosphorylated redox co-
factor is more expensive and less stable. Therefore,
several approaches were taken.9,14,37,40,41 One strat-
egy was based on crystal structure and analysis of
cofactor binding to allow the use of NAD+. The
site-directed mutagenesis to increase NAD+-affinity
was tried first. However, the best mutant apparently
still had 50-fold lower affinity compared to the wild
type and NADP+ affinity also decreased.37 Alterna-
tively, mutations were introduced leading to 4-fold
higher activity with NADH compared to the wild
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type (vmax = 80 U mg(protein)
–1) but the activity of
the wild type with NADPH was still 4-fold higher
(vmax = 355 U mg(protein)
–1).40 Whether activity towards
a substrate was also affected was not discussed. The
LbADH-mutant was used later in an oxidative ki-
netic resolution of phenylethanol with oxidative co-
factor regeneration by a NADH oxidase from
Lactobacillus brevis.41
Notably, additives such as organic solvents
(miscible and nonmiscible) or ionic liquids are in-
fluencing selectivity, activity, and/or half life.42–46
An aqueous two-phase system with the ionic li-
quid diethyl-methyl-polyethyleneglycol ammonium
chloride (Ammoeng110TM) could be utilised for the
extraction of LbADH. The system was optimised
by experimental design.45 The specific activity was
found to be twofold higher in the ionic liquid rich
phase. Furthermore, the storage half-life at 30 °C
was increased 10-fold from 14 h to 142 h by addi-
tion of 30 % (w/w) ionic liquid. In biphasic systems
of aqueous buffer and organic solvents storage sta-
bility44,47 and operational stability43,48 were found to
be unusually high with half-life in the range of sev-
eral hundred hours.
Biotransformations
The application of LbADH in biotransformation
was pioneered by Hummel and coworkers as dis-
cussed in Hummel et al.20 The bioorganic potential
was exploited earlier on by the group of Müller.26
Substrate scope
Substrates that can be converted by LbADH
are shown in Fig. 4 and classified into groups from
1 to 15. Generally, ketones are converted that have
preferential short chain substitution (methyl-, ethyl-)
and are not too sterically demanding on the other
residue. Notable exceptions are cyclohexanone de-
rivatives (12),20,49 2-hydroxy-phenyl-propanone (11),50,51
and diketones (8, 9, 10, Fig. 3).39 Interestingly, only
2,3-diketones are reduced to the corresponding diols
with high diastereoselectivity for 2,3-diketo-hexane
and -heptane to the syn-alcohols (2R,3S).39 This is
in accordance with the reduction of 1,2-hydroxy ke-
tones such as 2-hydroxy-phenyl-propanone50,51 and
hydroxy-propanone (13).3,20 2,4-Diketones are
regioselectively reduced only in 2-position (10).39
Acetophenone is widely used and also 4-nitro-
and 4-ethyl-acetophenone, methyl-naphtyl-ketone,
as well as all monosubstituted chloro-aceto-
phenones are accepted with varying activity
(11)3,20,52–54 as is 4-acetylpyridine.55 Benzaldehyde
and propiophenone are accepted with low activity
(11).3,20
Widely used are also ketoesters such as 2-oxo-
-ester (3),3,20 3-oxo-esters (4),3,20,53,56–59 4-oxo-esters
(5),3 and 5-oxo-ester (6).3 When 3,5-dioxo-esters
(7)60–66 are transformed, the easiest accessible oxo-
-groups in view of steric hindrance are reduced.
A C-C triple bond in so-called propargylic ke-
tones is also accepted in substrates (14),11,32,67,68 as
well as C-C double bonds in allylic ketones (15).69
All aliphatic linear 2-oxo-alkanes from chain-
-lengths C3 up to C11 (1) are accepted as substrates
whereupon the achievable enantiomeric excesses
increase with increasing chain length. Butanone
gives rise to varying enantioselectivity between
 0.3242 and >0.90.48 The reduction of 2-pentanone
through 2-heptanone is reported without giving
enantioselectivity.70 For the reduction of 2-octanone
and 2-nonanone, high enantiomeric excesses are re-
ported.23,42,48,52,70–72 Partly, solubilisers such as
acetonitrile,42 dioxane,70 or ionic liquids45,46 are
used with low influence on the enantioselectivity.
Applications
Whole cells of recombinant E. coli were ap-
plied for the reduction of methyl-3-keto-butanoate
(4) with 2-propanol as reducing agent.57,73 The au-
thors developed a quantitative model for the pro-
cess based on in vitro kinetics and metabolic cofac-
tor concentration with more than 40 model parame-
ters. The regeneration of the cofactor and LbADH
expression were identified as rate limiting. The lim-
itation in view of cofactor regeneration could ap-
parently be circumvented by coexpression of a
NAD+ dependent formate dehydrogenase (FDH) from
Mycobacterium vaccae N10 along with LbADH58
with an approximately doubled productivity per cell
mass (40 mmol gCDM
–1 d–1) vs. 290 mmol gCWM
–1 d–1)
(CWM: cell wet mass, CDM: cell dry mass).
Alginate immobilised whole cells were used
for transformations of a variety of -keto esters (4).
Immobilisation allowed up to 10 recycles without
apparent loss in activity.59 The higher the cell load-
ing in the immobilisates, the slower the apparent re-
action rate or the conversion obtained after a given
time. Cell agglomeration and mass transport limita-
tions were discussed briefly by the authors. Recy-
cling improved as after 14 cycles, the conversion
with free cells had dropped from more than 0.9 to
0.05, whereas with the immobilised cells conver-
S. LEUCHS and L. GREINER, Alcohol Dehydrogenase from Lactobacillus brevis: …, Chem. Biochem. Eng. Q. 25 (2) 267–281 (2011) 269
F i g . 3 – Diketones used as substrates39
sion better than 0.7 was obtained, which is in line
with cell recovery. Continuous experiments in a
packed bed plug flow reactor could be run for more
than 40 h (13 residence times) at STY = 25 g L–1 h–1
for ethyl-(R)-3-hydroxybutyrate. Both in the batch-
wise recycling as well as in the continuous reac-
tions, the immobilisation conditions such as pH and
ions used in the hardening, affected the stability of
the catalyst system.
A whole cell biotransformation with over-
expressed LbADH and FDH from Mycobacterium
vaccae N10 in E. coli for the reduction of 4-chloro-
-acetophenone (11), ethyl-4-chloroacetoacetate (4),
and 1-phenyl-2-chloroethanone (11) was performed
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F i g . 4 – Overview of substrate motifs as converted by LbADH to the corresponding R-ketones,
possible residues can be found in the ESI
in biphasic systems with 9 and 10 ionic liquids, re-
spectively.53,54 The authors proposed a selection
procedure for the ionic liquid based on testing of
the membrane integrity and rating criteria.53 In the
follow-up work, a FDH from Candida bodinii
was used for the reduction of 2-octanone (1) and
4-chloro-acetophenone (4).52 The number of ionic
liquids was increased to 21. As in the previous work,
a bis[(trifluormethyl)sulfonyl]amide (BTA) based
ionic liquid gave best yields and was chosen for a
200 mL scale-up to a fed batch with 0.18 kg L–1 d–1.
The reduction of tert-butyl-6-chloro-3,5-dioxo-
-hexanoate (7) to tert-butyl-6-chloro-5R-hydroxy-
-3-oxo-hexanoate was chosen for optimisation
of reaction conditions as the best candidate for
statin synthesis among 12 substrates converted by
LbADH.10,61,62,65 The chemical side reaction of this
specific substrate, namely the elimination of HCl
giving a stable 5-member furanone, was suppressed
by adjusting pH to 5.5 and keeping the substrate
concentration low via fed batch operation of the
stirred loop reactor.60,66 Alternatively, a biphasic
approach with methyl-tert-butylether (MTBE) as
non-reactive phase was described.47,61,66 At higher
concentrations, this approach gave up to 10-fold
higher turnover numbers of the cofactor NADP+.
However, selectivity with the competing chemical
side reaction dropped to 0.7 with increased sub-
strate concentration. For acetophenone (11) at low
concentrations of 1 mmol L–1, a repetitive batch
with at least four recycles is described and the en-
zyme half-life is given as 480 h.47,66
The influence of acetonitrile and 1,4-dioxane
as cosolvents for the reduction of butanone (1)
on enantiomeric excess and half-life was investi-
gated.42 Half-life was generally reduced with in-
creasing molar fraction of organic cosolvents from
400 h in buffer down to 1.6 h with x = 0.10 aceto-
nitrile. Enantioselectivity also depended on the mo-
lar fraction of these cosolvents and marginally in-
creased with higher amounts from 0.37 in aqueous
buffer to 0.43 with x = 0.100 and x = 0.050 with
acetonitrile and 0.40 at x = 0.100 1,4-dioxane.42
To convert hardly water-soluble ketones such
as 2-octanone, 3-octanone, 2-nonanone and 2-de-
canone (1), ionic liquids (IL) were used as
solubiliser.46 For cofactor regeneration glucose de-
hydrogenase (GDH) catalysed oxidation of glucose
was chosen. From an initial set of 10 water-miscible
IL, the AMMOENGTM101 was subsequently
used. The kinetic characterisation revealed that
AMMOENGTM101 activated and stabilised the
LbADH. For all four ketones tested, product inhibi-
tion was much lower when 200 g L–1 IL was added
compared to the pure buffer. The half-life increased
from 49 h to 158 h in 200 g L–1 IL/buffer-mixture.
Optimised batches with cofactor regeneration via a
glucose dehydrogenase and glucose as co-substrate
gave TONLbADH of 842,000, TONGDH of 19,000 and
TONNADP+ of 800.
The immobilisation of LbADH on a commer-
cial amino-epoxy support was optimised aiming for
increased stability.74,75 Immobilisation yielded 0.15
of the activity and half-life of about 20 h at 30 °C
similar to the one found in solution, in line with the
observation that the enzyme is readily desorbed in a
1 mol L–1 sodium chloride solution. However, treat-
ment with glutardialdehyde gave half-life of more
than 1000 h with 0.4 activity before treatment.
Combination of mercaptoethanol and glutardial-
dehyde treatment yielded 0.2 of activity with a
half-life of 500 h. The process stability was demon-
strated in a packed bed plug flow reactor where the
immobilised enzyme with combined treatment gave
a steady state conversion of 0.6 over more than
1500 h (1 h residence time) for the reduction of
acetophenone (11) via substrate coupled cofactor
regeneration with 2-propanol.
An alternate method for immobilising enzymes
or rather LbADH together with the cofactor is de-
scribed by.5,55 Both enzyme and cofactor were ab-
sorbed by a superabsorbent polymer, namely Fa-
vor®, and dried afterwards. The so prepared catalyst
was then used for the enantioselective reduction of
acetophenone, 4-acetylpyridine (11, Fig. 5) and
ethyl-3-oxobutanoate (4). Exclusively the R-enan-
tiomer was formed with almost quantitative con-
version. The superabsorbed catalyst was easily sep-
arated from the reaction mixture and reused
four times in a repetitive batch mode. In total,
0.016 mmol product per U were synthesised with
TONNADP+ = 900.
For the application of whole cells in the contin-
uous synthesis of methyl-(R)-3-hydroxybutanoate
(4), different cofactor regeneration techniques were
tested.72,73 Cells, over-expressing LbADH were used
in the substrate coupled approach with 2-propanol,
or regeneration enzymes like glucose dehydro-
genase from Bacillus megaterium (GDH together
with glucose facilitator GLF from Zymomonas
mobilis) or formate dehydrogenase (FDH) from
Mycobacterium vaccae N10 were coexpressed
(GDH/GLF,FDH in analogy to58). The performance
of the so produced cells was subsequently exam-
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F i g . 5 – 4-acetylpyridine used as sub-
strate by55
ined in a stirred loop reactor (Fig. 6) with retention
of the cells in a bypass. The operational stability of
both of the enzyme coupled approaches turned out
to be rather low with deactivation constants of
0.96 d–1 (FDH, half-life 17 h) and 0.219 d–1 (GDH,
half-life 76 h). The deactivation constant using
2-propanol for cofactor regeneration was two
orders of magnitude smaller (0.0059 d–1, half-life
2500 h) leading to a stable process for 45 days
with a maximum STY of 6 mol L–1 d–1. Producing
2-butanol (1) with the same setup gave a 3-fold
higher deactivation of 0.016 d–1 (half-life >1000 h)
with a maximum STY of 4 mol L–1 d–1. For
methyl-(R)-3-hydroxybutanoate the ee was >0.99.
For 2-butanol no data concerning ee is given.
In a two-phase system with MTBE as second
phase, using isolated enzymes, the enzyme coupled
cofactor regeneration seemed to be favourable.23
For the reduction of 2-octanone (1), cofactor regen-
eration with 2-propanol or with GDH/glucose was
adopted. In this case, the 2-propanol system was in-
ferior to the GDH/glucose system due to equilib-
rium constraints. So, a conversion of 75 % was
reached with the GDH/glucose system within 1 h,
with 2-propanol as reducing agent, the same con-
version was reached only after a reaction time of al-
most 2 h. Also, the authors hint towards repetitive
batch application by replacing the organic phase.23
If cofactor regeneration is done via oxidation
of 2-propanol, removal of acetone is always an is-
sue regarding equilibrium constraints. In Eckstein
et al.71 2-octanone (1) was used as substrate with
isolated LbADH. To remove acetone, two two-phase
approaches were tested, one with MTBE and one
with [BMIM][CF3(SO2)2N] as second phase. The
partition coefficient for acetone in the IL/buffer
system was higher (2.0) than for 2-propanol (0.4)
in contrast to the equal partition coefficients for
both components in the MTBE/buffer-system with
1.1/1.0, respectively. Thus, the selective extraction
of acetone in the IL/buffer-system led to a higher
reaction rate than in the MTBE/buffer-system. The
conversion was not strongly affected in this case,
which was probably due to the 200-fold excess of
2-propanol.71 Another approach used the same IL,
[BMIM][CF3(SO2)2N], and MTBE as second phase
for in situ acetone removal.76 In this case, the con-
version of 1-phenyl-2-propanone (2) was investi-
gated. If MTBE was used as a second phase, the
yield was restricted to 24 %, using the ionic liquid
[BMIM][CF3(SO2)2N] as a second phase, yields
of 95 % could be achieved. This fact is due to
the different partition behaviour of acetone in
the buffer/MTBE and buffer/[BMIM][CF3(SO2)2N]
system. In the enantioselective reduction of
2,5-hexanedione (5) to the corresponding diol,
equilibrium constraints play a key role if the sub-
strate coupled approach is used because two equiv-
alents of acetone are formed. Different non-extrac-
tive acetone removal techniques like stripping and
pervaporation were tested.73,76 Without acetone re-
moval, the yield was limited to 55 %. Pervaporation
and stripping led to increased yields of 90 and
95 %, respectively. Further stability investigations
showed that pervaporation guarantees the highest
catalyst stability when compared to stripping and
extraction with IL. These findings were later ap-
plied for the continuous synthesis of the same target
molecule, 2(R),5(R)-hexanediol.73,77 A continuous
setup was built up with in situ acetone removal by
pervaporation, leading to a maximum space time
yield of 1.4 mol L–1 d–1 at a maximum yield of
77 %.
In contrast to the above-mentioned findings, in78
results are reported when reducing butanone (1)
to (R)-2-butanol using 2-propanol as reducing
agent. After 2 h reaction time, generally higher
conversions and comparable ee were reached
when using a MTBE/buffer-system instead of a
[PMIM][PF6]/buffer-system, although the IL
showed miscibility with acetone and no miscibility
with the reducing agent 2-propanol. An alterna-
tive approach was tested with a malate de-
hydrogenase (MDH) and L-malic acid as reducing
agent, but ee were lower. Hence, 2-propanol in a
MTBE/buffer-system was tested for the continuous
production of (R)-2-butanol in a minimum volume
(2 to 5 mL) biphasic reactor with aqueous buffer
and MTBE.43,48 A space-time yield of 200 mmol L–1 d–1
with the ee starting from  95 % dropping to
 85 % after 90 h operation is reported.
The production of -hydroxyesters (4) on an in-
dustrial scale was already established by Wacker
(Burghausen, Germany).7,22,34,35,56 In repetitive batch,
methyl-3-oxobutanoate was reduced to the corre-
sponding hydroxybutanoate, the cofactor regenera-
tion was achieved by substrate coupled regeneration
with 2-propanol. The co-product acetone was re-
moved by reduced pressure and the target product
was isolated from the reaction mixture by continuous
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F i g . 6 – Stirred loop reactor with filtra-
tion as used by Schroer et al.,72
P = pump, M = filtration module
extraction with MTBE and subsequent distillation of
the solvent. The product-free enzyme-solution was
then re-used leading to a TON for the cofactor of
74,000 and a space-time-yield of 92 g L–1 d–1.
For the prediction of thermodynamic conver-
sion and yield in various biphasic systems LbADH
was used as model catalyst for the reduction of
acetophenone (11) with 2-propanol. An analytical
equation was derived to allow prediction of conver-
sion and yield from the equilibrium constant and
the partition coefficients, and the implications for
maximising them are discussed.49 The prediction is
shown for 8 biphasic systems including two ionic
liquids. The lack of data in view of equilibrium
constants and possible means of deriving them from
alternative sources are further discussed and evalu-
ated.70 The approach with computational chemistry
was developed further.79,80
Freeze-dried preparations of LbADH are active
for conversion of gaseous reactants. By optimising
immobilisation conditions on coated glass beads
with the addition of sucrose, a half-life of 40 days
under reaction conditions in a packed bed plug flow
reactor was possible.81 The effect of sucrose on the
adsorption isotherms was investigated in detail later
showing that sucrose lowers water adsorption per
protein as well as the adsorption of acetophenone
(11) and isopropanol.82 Furthermore, the enzyme
coated glass beads tended to decrease in protein
loading and sinter in the presence of water, as
shown by scanning electron microscopy (SEM). In
a study centered on yeast ADH (yADH) the influ-
ence of pressure during freeze drying was investi-
gated and specific activity after redissolution was
found to be up 3-fold higher than of the initial
LbADH preparation at about 40 kPa.83 The effect of
pressure, water activity, cofactor to protein ratio,
and temperature on the reduction of acetophenone
by an immobilised LbADH were investigated.
LbADH was applied as lyophilisate on glass beads
in a packed bed reactor for the reduction of aceto-
phenone with STY of up to 1 kg L–1 d–1 at 60 °C
calculated on the basis of the packed volume at
half-life of 1 day.84 The authors point out that oper-
ational half-life for gas phase reactions cannot be
correlated with storage stability.
Dense propane can also be applied as non-reac-
tive phase for LbADH catalysed transformations.85
Both an aqueous/dense propane-biphasic system or
a monophasic dense propane system with LbADH
-lyophilisate immobilised on glass beads were in-
vestigated.85 For the synthesis of (R)-phenylethanol
(11), using the biphasic system led to 90 % conver-
sion of acetophenone whereas the reaction with im-
mobilised LbADH gave only 45 % conversion. This
was in contrast to deactivation investigations. At
30 bar propane, in aqueous solution LbADH was
less stable (t1/2 = 0.2 h, 35 °C) than a corresponding
freeze-dried preparation (t1/2  1 h, 34 °C).
Several multi-step one-pot syntheses including
one step being catalysed by LbADH are reported.69,86,87
Chiral allylic alcohols (15) were obtained in a
two-step synthesis by converting the product, an
allylic ketone, of a Pd-catalysed Heck-reaction of
aryliodides with butenone by simply adding buffer,
cofactor, 2-propanol and LbADH to the transi-
tion-metal containing reaction mixture.69 High
space-time-yields of >1.0 mol L–1 d–1 and yields
between 20 and 80 % were realised with this
method.69 A similar approach to phenylethanol de-
rivatives (11) was published later by the same
group.87 Here, the first step was a Pd-catalysed cou-
pling of aryliodides with acetic anhydride, which
led to the corresponding acetophenone derivatives.
Hydrolysing excess acetic anhydride was achieved
by heating the reaction mixture with aqueous
buffer. The enzymatic step was started by adding
LbADH, NADP+ and 2-propanol. Two diketo-aceto-
phenone derivatives were converted in a three-step
one-pot synthesis to give hydroxy acids (11).86 In
this case, the regioselectivity of LbADH was uti-
lised to reduce a ketone in the presence of an
aldehyde, while the aldehyde was reduced by an
aldoketo reductase from E. coli (ECAKR). The oxi-
dation of the primary alcohol was then performed
by a dihydrodiol dehydrogenase from Pseudomo-
nas fluroescens to give the corresponding acid. Ex-
cept LbADH, all enzymes were used as whole-cell
catalysts in E. coli. All three steps were carried out
in one reaction mixture with the biocatalysts added
stepwise after completion of the preceeding step.
The medium always contained NADP+ and 2-pro-
panol for cofactor regeneration, although, no in-
termediate workup had to be carried out. On a
250 mg-scale, (2S)-hydroxy(phenyl)ethanoic acid
(mandelic acid) was obtained with an overall yield
of 90 % and an ee of 99 % and 3-[(1R)-1-hydroxy-
ethyl]benzoic acid with an overall yield of 90 %
(ee = 99 %).
Electrochemical cofactor regeneration methods
were not possible due to the lack of stability of
LbADH in the presence of the redox mediator used,
a rhodium bipyridin complex88 (Fig. refechemie)
and due to the adsorption of the enzyme on the po-
rous carbon felt and subsequent deactivation.75,89
After deactivation of the enzyme, the ee decreased
dramatically due to the unselective direct reduction.
Several approaches were tested to overcome these
limitations. Adding a second protein, such as bovine
serum albumin (BSA) kept the enzyme in solution
and led to a TON of 74,000 for LbADH with an ee
of >99.9 and a productivity of 120 mmol L–1 d–1 for
(R)-phenylethanol (11).89 By means of immobilisa-
tion, a direct contact of LbADH with the carbon felt
S. LEUCHS and L. GREINER, Alcohol Dehydrogenase from Lactobacillus brevis: …, Chem. Biochem. Eng. Q. 25 (2) 267–281 (2011) 273
was avoided, thus a TONLbADH of 21,000 with
a productivity of 74 mmol L–1 d–1 for (R)-phenyl-
ethanol (11) was possible.89 The ee dropped slightly
to >98.0 due to the direct reduction in compart-
ments of the reactor where no enzyme was present.89
Using a two-phase system with MTBE as second
phase for the same substrate, acetophenone (11), the
space-time-yield dropped to 25 mmol L–1 d–1 with
the conversion not exceeding 60 %. These dis-
advantages may be overcome by the facilitated
downstream-procedure in this case.89 The spacial
separation of LbADH immobilised on Sepabeads®
from the polymer enlarged electrochemical media-
tor (Rhbpy) led to enhanced catalyst stability,
so that electroenzymatic synthesis was possible
with a linear product formation rate for (R)-4-chloro-
-phenylethanol (11) of 0.42 mmol L–1 h–1 and a
space time yield of 10 mmol L–1 h–1. One main
drawback of this approach was the low TON of 3
for the cofactor.75,90 The relatively complicated con-
figuration for electroenzymatic synthesis as com-
pared to a simple substrate coupled cofactor regen-
eration approach may be considered as another
drawback.
Finally, the high stability and activity of
LbADH was also used for simple cofactor regenera-
tion in the hydroxylation of steroids to the corre-
sponding 15-hydroxy products.91 For the hydroxy-
lation step, the soluble P450 monooxygenase,
CYP106A2 from Bacillus megaterium ATCC 13
368 was used. This enzyme requires an electron
transfer partner, in this case bovine adrenodoxin
(Adx), which was coexpressed together with the
CYP106A2 in Escherichia coli. Adx acts as elec-
tron transfer agent from NADPH to CYP106A2,
the cofactor regeneration was carried out by
LbADH using 2-propanol as reducing agent (Fig.
8). Growing and resting cells of E. coli were tested
as well as crude cell extract (CCE). Resting cells
gave better conversion and less side products when
compared to growing cells. Because steroids are not
actively transported through the cell membrane,
CCE was tested and showed higher activity, but
also a higher amount of side products compared to
resting whole cells. After optimization, a space time
yield of up to 18.3 mmol L–1 d–1 was achieved with
CCE.
Another approach using LbADH for cofactor
regeneration is the concurrent production of two
enantio-enriched compounds.92 The main reaction
here was the oxidative kinetic racemic resolution
of a ketone to the corresponding ester or sulfide
oxidation to the corresponding sulfoxide by two
Baeyer-Villiger monooxygenases (BVMO). BVMO
need NADPH as redox equivalents with NADP+
as coupled product. The in situ regeneration was
done by the oxidation of an alcohol by LbADH or
ADH from Thermoanaerobacter species (ADH-T).
In this case, the kinetic racemic resolution of a
long-chain alcohol (2-octanol, 2-undecanone,
2-hydroxy-6-methyl-hept-5-en (1)) was used for
LbADH-catalysed cofactor-regeneration. Only for
high conversion, high ee is possible for the
non-converted substrates. ee for the alcohols was
between 27 and 99 % depending on subtrates
and enzyme combination. The authors do not com-
ment on solubility restrictions of the long chain al-
cohols.
In a dynamic kinetic resolution, the sponta-
neous racemisation of tert-butyl-4-methyl-3,5-di-
oxo-hexanoate (7) was exploited to reduce the
4S,5R-alcohol64 with ee = 99.2 % and 94 % dia-
stereomeric excess.64,65 The access to two other of
the four possible diastereoisomers by using other
biocatalysts is also described.93
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F i g . 7 – Reaction scheme for the reduction of acetophenone
to R-phenylethanol with electrochemical cofac-
tor-regeneration89,90
F i g . 8 – Reaction scheme for the hydroxylation of steroids
with monooxygenase CYP106A291
Conclusion
LbADH is a versatile and robust catalyst. Fur-
thermore, the tolerance of organic solvent/IL etc. as
additives, as well as biphasic media, and gaseous
dense reaction conditions is outstanding for an
oxidoreductase. The substrate scope is broad and
high regio- and stereospecifity can be obtained. Es-
pecially, the 2-keto motif has a high probability to
be converted with high selectivity and activity.
Here, the tolerance of organic cosolvents and
biphasic systems allow compensation for water as
the reaction medium. LbADH is used as whole-cell
catalyst in E. coli as well as isolated enzyme, solu-
ble or immobilised (Fig. 9). A priori, no choice for
one of the regeneration methods can be substanti-
ated. When isolated enzymes are used, the ratio
LbADH / regeneration enzyme can be chosen inde-
pendently. In whole-cell processes, intracellular co-
factor concentrations are mostly sufficient, but ex-
pression levels of the enzymes are rather difficult to
influence. This is especially an issue if cofactor re-
generation is done in an enzyme-coupled approach,
so that two enzymes are coexpressed in one organ-
ism. Different experiments have shown, that
half-life of LbADH strongly depends on the pres-
ence of cofactor, magnesium, additives or organic
cosolvents, pH and the nature of the buffer, ion
strength, temperature, water activity, immobilisa-
tion, as well as non-miscible phases, and varies
from single hours to more than 1000 h. Therefore,
if stability is investigated, care has to be taken to
ensure that process conditions are covered by ex-
periments; otherwise, strong deviations from stor-
age stability to process stability occur.
A b b r e v i a t i o n s
BSA  bovine serum albumin
BTA  bis[(trifluoromethyl)sulfonyl]amide
BVMO  Bayer Villiger monooxygenase
CALB  B lipase from Candida antarctica
CCE  crude cell extract
CIP  Cahn-Ingold-Prelog
DCM  dry cell mass
ECAKR aldoketo reductase from Escherichia coli
E. coli  Escherichia coli
ee  enantiomeric excess
ESI  electronic supporting information
FDH  formiate dehydrogenase
GDF  glucose facilitator from Zymomonas mobilis
GDH  glucose dehydrogenase
IE  isolated enzyme
IL  ionic liquid
LbADH  alcohol dehydrogenase from Lactobacillus
brevis
LkADH  alcohol dehydrogenase from Lactobacillus
kefir
MDH  malate dehydrogenase
MTBE  methyl-tert-butylether
NAD+  nicotinamide adenine dinucleotide (oxidised
form)
NADH  nicotinamide adenine dinucleotide (reduced
form)
NADP+  nicotinamide adenine dinucleotide phosphate
(oxidised form)




scF  supercritical Fluid
SEM  scanning electron microscopy
TON  turnover number
WC  whole cell
WCM  wet cell mass
yADH  alcohol dehydrogenase from yeast
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F i g . 9 – Overview of the applications of LbADH with num-
ber of citations (the diameter of the circles is pro-
portional to the number of citations)
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